Optical Coherence Tomography in Multiple Sclerosis Patients
| Status: | Completed |
|---|---|
| Conditions: | Neurology, Ocular, Multiple Sclerosis |
| Therapuetic Areas: | Neurology, Ophthalmology, Other |
| Healthy: | No |
| Age Range: | 18 - 65 |
| Updated: | 5/5/2014 |
| Start Date: | August 2012 |
| End Date: | June 2013 |
| Contact: | Lucy Xu, BSc. |
| Email: | xut@ccf.org |
| Phone: | 414-292-6036 |
To evaluate the ability of different spectral domain optical coherence tomography (OCT)
devices, as well as different acquisition and analysis packages, to detect disease
progression in patients with multiple sclerosis with and without a history of optic neuritis
devices, as well as different acquisition and analysis packages, to detect disease
progression in patients with multiple sclerosis with and without a history of optic neuritis
Optical coherence tomography imaging of the retina has been shown to be an effective non
invasive method to study retinal changes associated with multiple sclerosis induced optic
neuritis. The retina is a unique structure in that it is an unmyelinated part of the central
nervous system (CNS). However, it is uncertain which layer of the retina provides the best
correlation with MS disease. The investigators propose a prospective, case-control study to
compare OCT measurements from different parts of the retina of MS patients with optic
neuritis, those without optic neuritis, and healthy controls. The investigators will then
correlate the OCT measurements to clinical measures of disease. This will allow future
studies to use OCT technology as a primary outcome in studying MS axonal and cell body
injury of the CNS, as well as evaluating strategies in treating MS.
invasive method to study retinal changes associated with multiple sclerosis induced optic
neuritis. The retina is a unique structure in that it is an unmyelinated part of the central
nervous system (CNS). However, it is uncertain which layer of the retina provides the best
correlation with MS disease. The investigators propose a prospective, case-control study to
compare OCT measurements from different parts of the retina of MS patients with optic
neuritis, those without optic neuritis, and healthy controls. The investigators will then
correlate the OCT measurements to clinical measures of disease. This will allow future
studies to use OCT technology as a primary outcome in studying MS axonal and cell body
injury of the CNS, as well as evaluating strategies in treating MS.
Inclusion criteria (MS with acute optic neuritis group):
- History of unilateral optic neuritis as a manifestation of multiple sclerosis.
- Age between 18 and 65, inclusive.
- Ability to perform adequate OCT exam.
- Able to provide informed consent to participate in study.
Exclusion criteria (MS with acute optic neuritis group):
- Refractive error greater than ±6 diopters.
Inclusion criteria (MS without acute optic neuritis group):
- History of multiple sclerosis without optic neuritis
- Age between 18 and 65, inclusive.
- Ability to perform adequate OCT exam.
- Able to provide informed consent to participate in study.
Exclusion criteria (MS without acute optic neuritis group):
- Refractive error greater than ±6 diopters.
Inclusion criteria (healthy controls):
- Age between 18 and 65, inclusive.
- Ability to perform adequate OCT exam.
- Able to provide informed consent to participate in the study.
Exclusion criteria (healthy controls):
- Prior history of neurological disease.
- First degree relative with MS.
- Refractive error greater than ±6 diopters.
We found this trial at
1
site
Click here to add this to my saved trials
